ClinicalTrialsFinder

Mesothelioma, Malignant Pleural Clinical Trials in Beijing

1 recruitingBeijing, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma

Mesothelioma, MalignantMesothelioma, Malignant PleuralMesothelioma Malignant Advanced
Cancer Institute and Hospital, Chinese Academy of Medical Sciences29 enrolled2 locationsNCT05188859